The company is a provider of integrated clinical research technology solutions to pharmaceutical biotechnology and medical device companies and other organizations.


Updates from The Motley Fool

Latest updates on Biocept from Fool.com.

There is no available coverage of Biocept at this time.



Stock Performance

BIOC vs. S&P 500 | 2 Year Performance
View Interactive BIOC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Biocept.
Current Price: $0.56
Prev Close: $0.59
Open: $0.59
Bid: $0.56
Ask: $0.58
Day's Range: $0.56 - $0.60
52wk Range: $0.49 - $2.76
Volume: 160,672
Avg Vol 224,574
Market Cap: $10.53M
P/E (ttm): -0.52
EPS (ttm): -$1.13
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Biocept.
CAPS Rating 0 out of 5
 
9 Outperform
7 Underperform
CAPS All Stars
 
0 Outperform
4 Underperform

How do you think Biocept will perform against the market?



You pick for Biocept is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael Nall, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Biocept.

The company is a provider of integrated clinical research technology solutions to pharmaceutical biotechnology and medical device companies and other organizations.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT